Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Taurine | 5 | 2000 | 9 | 0.460 |
Why?
|
| Wnt Signaling Pathway | 4 | 2021 | 67 | 0.440 |
Why?
|
| Kidney | 9 | 1994 | 289 | 0.420 |
Why?
|
| Snakes | 7 | 1992 | 8 | 0.390 |
Why?
|
| Kidney Tubules, Proximal | 3 | 2016 | 15 | 0.360 |
Why?
|
| Receptors, LDL | 2 | 2021 | 28 | 0.350 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2021 | 99 | 0.330 |
Why?
|
| Macular Degeneration | 2 | 2021 | 86 | 0.330 |
Why?
|
| Fellowships and Scholarships | 1 | 2007 | 42 | 0.270 |
Why?
|
| Teaching | 1 | 2007 | 84 | 0.250 |
Why?
|
| Education, Medical, Graduate | 1 | 2007 | 119 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2020 | 125 | 0.250 |
Why?
|
| Nerve Growth Factors | 2 | 2016 | 24 | 0.240 |
Why?
|
| Fibrosis | 3 | 2021 | 143 | 0.240 |
Why?
|
| Serpins | 2 | 2016 | 31 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 346 | 0.210 |
Why?
|
| Eye Proteins | 2 | 2016 | 207 | 0.210 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 148 | 0.210 |
Why?
|
| Sodium | 5 | 1994 | 50 | 0.200 |
Why?
|
| Diabetic Nephropathies | 2 | 2020 | 21 | 0.190 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2021 | 3 | 0.180 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 11 | 0.180 |
Why?
|
| Animals | 21 | 2021 | 10756 | 0.180 |
Why?
|
| ADAM17 Protein | 1 | 2021 | 13 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 1522 | 0.170 |
Why?
|
| Flounder | 1 | 2000 | 1 | 0.160 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2020 | 1 | 0.160 |
Why?
|
| Smad3 Protein | 1 | 2020 | 10 | 0.160 |
Why?
|
| Smad2 Protein | 1 | 2020 | 17 | 0.160 |
Why?
|
| Kidney Tubules | 1 | 2020 | 22 | 0.160 |
Why?
|
| Microvilli | 4 | 1994 | 7 | 0.160 |
Why?
|
| Nerve Degeneration | 1 | 2020 | 23 | 0.160 |
Why?
|
| PPAR alpha | 1 | 2020 | 44 | 0.150 |
Why?
|
| Cornea | 1 | 2020 | 72 | 0.150 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 60 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 47 | 0.150 |
Why?
|
| Mice, Knockout | 5 | 2021 | 876 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2020 | 98 | 0.150 |
Why?
|
| Ureteral Obstruction | 1 | 2016 | 12 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2016 | 61 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2020 | 1482 | 0.120 |
Why?
|
| Amino Acids | 4 | 1992 | 85 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2016 | 267 | 0.110 |
Why?
|
| Ependymoglial Cells | 1 | 2014 | 32 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 124 | 0.110 |
Why?
|
| Colubridae | 1 | 1994 | 1 | 0.110 |
Why?
|
| Ischemia | 1 | 2014 | 83 | 0.100 |
Why?
|
| Cold Temperature | 1 | 2014 | 35 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 216 | 0.090 |
Why?
|
| Skin | 1 | 2014 | 155 | 0.090 |
Why?
|
| Cytokines | 1 | 2014 | 456 | 0.090 |
Why?
|
| Retina | 1 | 2014 | 445 | 0.080 |
Why?
|
| Dogfish | 1 | 1990 | 1 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1990 | 6 | 0.080 |
Why?
|
| Sharks | 1 | 1990 | 7 | 0.080 |
Why?
|
| Mice | 4 | 2021 | 4845 | 0.080 |
Why?
|
| Biological Transport | 4 | 1994 | 128 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 5 | 1990 | 48 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2021 | 1022 | 0.070 |
Why?
|
| Potassium | 2 | 1985 | 43 | 0.060 |
Why?
|
| Glutaminase | 2 | 1978 | 2 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2007 | 245 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 554 | 0.060 |
Why?
|
| Kinetics | 2 | 2000 | 553 | 0.060 |
Why?
|
| Magnesium | 1 | 1985 | 42 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 645 | 0.060 |
Why?
|
| Male | 7 | 2020 | 14049 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 1672 | 0.050 |
Why?
|
| Phenotype | 2 | 2016 | 688 | 0.050 |
Why?
|
| Membranes | 2 | 1994 | 8 | 0.050 |
Why?
|
| Humans | 6 | 2021 | 29078 | 0.050 |
Why?
|
| Anions | 2 | 1994 | 15 | 0.050 |
Why?
|
| Membrane Potentials | 2 | 1994 | 65 | 0.050 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2021 | 9 | 0.040 |
Why?
|
| Smad Proteins | 1 | 2021 | 18 | 0.040 |
Why?
|
| Osmolar Concentration | 2 | 2000 | 25 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 1619 | 0.040 |
Why?
|
| United States | 1 | 2007 | 2252 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 53 | 0.040 |
Why?
|
| Rats | 3 | 2020 | 1594 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 52 | 0.040 |
Why?
|
| Acidosis | 2 | 1978 | 11 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 79 | 0.040 |
Why?
|
| Bromcresol Green | 1 | 2000 | 1 | 0.040 |
Why?
|
| Probenecid | 1 | 2000 | 1 | 0.040 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2000 | 2 | 0.040 |
Why?
|
| Stimulation, Chemical | 1 | 2000 | 32 | 0.040 |
Why?
|
| Epithelium | 1 | 2000 | 40 | 0.040 |
Why?
|
| Fenofibrate | 1 | 2020 | 8 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2020 | 20 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 134 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 202 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2000 | 268 | 0.040 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1978 | 18 | 0.040 |
Why?
|
| Nephrectomy | 1 | 1978 | 48 | 0.030 |
Why?
|
| Chlorides | 2 | 1994 | 13 | 0.030 |
Why?
|
| Axin Protein | 1 | 2016 | 3 | 0.030 |
Why?
|
| Transfection | 1 | 2016 | 319 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1992 | 242 | 0.030 |
Why?
|
| Sheep | 1 | 1975 | 100 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 169 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1975 | 89 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 1 | 1975 | 10 | 0.030 |
Why?
|
| Ammonia | 1 | 1975 | 18 | 0.030 |
Why?
|
| Female | 5 | 1992 | 15740 | 0.030 |
Why?
|
| Pericytes | 1 | 2014 | 17 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 701 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 1975 | 183 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 108 | 0.030 |
Why?
|
| Hypoxia | 1 | 2015 | 90 | 0.030 |
Why?
|
| beta Catenin | 1 | 2014 | 66 | 0.030 |
Why?
|
| Chemistry | 1 | 1994 | 10 | 0.030 |
Why?
|
| Chemical Phenomena | 1 | 1994 | 22 | 0.030 |
Why?
|
| Mathematics | 1 | 1994 | 42 | 0.030 |
Why?
|
| Surface Properties | 1 | 2014 | 134 | 0.030 |
Why?
|
| Pressure | 1 | 2014 | 91 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 179 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 681 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 781 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 226 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 112 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 477 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 417 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 680 | 0.020 |
Why?
|
| Sodium Chloride | 2 | 1985 | 68 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1991 | 271 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 1990 | 5 | 0.020 |
Why?
|
| Aorta | 1 | 1990 | 124 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1990 | 358 | 0.020 |
Why?
|
| Species Specificity | 2 | 1986 | 196 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1990 | 612 | 0.020 |
Why?
|
| p-Aminohippuric Acid | 1 | 1988 | 1 | 0.020 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1988 | 2 | 0.020 |
Why?
|
| 3-O-Methylglucose | 1 | 1988 | 2 | 0.020 |
Why?
|
| Methylglucosides | 1 | 1988 | 2 | 0.020 |
Why?
|
| Seawater | 2 | 1985 | 42 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 94 | 0.020 |
Why?
|
| Dactinomycin | 2 | 1978 | 5 | 0.020 |
Why?
|
| Phosphates | 2 | 1978 | 33 | 0.020 |
Why?
|
| Cysteic Acid | 1 | 1986 | 1 | 0.020 |
Why?
|
| Cloaca | 1 | 1986 | 4 | 0.020 |
Why?
|
| Ureter | 1 | 1986 | 8 | 0.020 |
Why?
|
| beta-Alanine | 1 | 1986 | 12 | 0.020 |
Why?
|
| Diuresis | 1 | 1985 | 5 | 0.010 |
Why?
|
| Adaptation, Physiological | 2 | 1978 | 177 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 8080 | 0.010 |
Why?
|
| Urine | 1 | 1978 | 14 | 0.010 |
Why?
|
| RNA | 1 | 1978 | 111 | 0.010 |
Why?
|
| DNA | 1 | 1978 | 378 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1975 | 1 | 0.010 |
Why?
|
| Hypotonic Solutions | 1 | 1975 | 1 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1975 | 11 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1975 | 12 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1975 | 4 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1975 | 393 | 0.010 |
Why?
|
| Age Factors | 1 | 1975 | 740 | 0.010 |
Why?
|
| Vasotocin | 1 | 1985 | 2 | 0.000 |
Why?
|
| Vasopressins | 1 | 1985 | 4 | 0.000 |
Why?
|
| Body Water | 1 | 1985 | 19 | 0.000 |
Why?
|
| Phylogeny | 1 | 1985 | 496 | 0.000 |
Why?
|